Our previous study has shown that IGFBP2 is expressed in microvesicles released from NSCLC cells and is highly expressed in the marginal region of NSCLC tumors, indicating its potential role in remodeling the tumor microenvironment [13]. The gene discussed is IGFBP2; the disease is non-small cell lung carcinoma.